Post

AstraZeneca, Daiichi Sankyo’s Datroway receives FDA approval for TNBC

AstraZeneca and Daiichi Sankyo have secured approval from the US Food and Drug Administration (FDA) for Datroway (datopotamab deruxtecan) to …
Q&A: How 3PLs are navigating the latest pharma trends

Pharmaceutical third-party logistics (3PL) providers are moving beyond traditional warehousing into more holistic and strategic commercialization support. At the same …
CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati

One of Italy’s only publicly traded large pharma companies could soon be taken into private ownership, after private equity firm …
Accelerate post-approval research by streamlining the entire study lifecycle

As oncology therapies mature, post-approval research is essential to supporting regulatory commitments, label expansion, and real-world adoption—often under tight timelines. …
European STI cases reach record high amid testing and prevention gaps

New data debuted by the Europe’s infectious disease agency has revealed that cases of certain bacterial sexually transmitted infections (STIs) …

Pierre Fabre’s Braftovi gains CHMP positive opinion for mCRC

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval …
AstraZeneca, Daiichi Sankyo’s Datroway receives FDA approval for TNBC

AstraZeneca and Daiichi Sankyo have secured approval from the US Food and Drug Administration (FDA) for Datroway (datopotamab deruxtecan) to …
Q&A: How 3PLs are navigating the latest pharma trends

Pharmaceutical third-party logistics (3PL) providers are moving beyond traditional warehousing into more holistic and strategic commercialization support. At the same …
CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati

One of Italy’s only publicly traded large pharma companies could soon be taken into private ownership, after private equity firm …
Accelerate post-approval research by streamlining the entire study lifecycle

As oncology therapies mature, post-approval research is essential to supporting regulatory commitments, label expansion, and real-world adoption—often under tight timelines. …
European STI cases reach record high amid testing and prevention gaps

New data debuted by the Europe’s infectious disease agency has revealed that cases of certain bacterial sexually transmitted infections (STIs) …
Gilead Sciences completes Tubulis acquisition for $5bn

Gilead Sciences has concluded its acquisition of Tubulis, a Germany-based biotechnology company developing next-generation antibody-drug conjugates (ADCs), in a transaction …
Concept Life Sciences and OpenBench partner on drug discovery services

Concept Life Sciences has signed a strategic partnership with OpenBench to deliver success-based drug discovery services targeted at early-stage biotech …
Gilead teams up with WHO again to eliminate parasitic tropical disease

Gilead has pledged over 400,000 doses of its antifungal medication to countries affected by a parasitic tropical disease as part …
How price variation impacts employers

This is the first episode in our second season exploring the evolving landscape of real-world data and its role in …